StockData
Rockwell Medical, Inc. logo

Rockwell Medical, Inc. (RMTI) stock

RMTINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3080% below fair value
$6.61−0.15 (-2.22%)

Close on Nov 17, 2026Market cap $26.64MP/E –Yield –

Rockwell Medical enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Rockwell Medical's enterprise value was $265.42M on Nov 11, 2026, against $24.26M a year earlier. Over the last 5 years it ranged from -$6.06M to $323.41M, with a median of $29.18M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$265.42M+1384.4%
2025Dec 31, 2025$17.88M-68.1%
2024Dec 31, 2024$56.01M+9.6%
2023Dec 29, 2023$51.11M–
2022Dec 30, 2022-$2.24M-108.4%
2021Dec 31, 2021$26.55M-44.7%
2020Dec 31, 2020$48.05M-66.0%
2019Dec 31, 2019$141.46M+25.5%
2018Dec 31, 2018$112.71M-62.1%
2017Dec 29, 2017$297.36M-6.6%
2016Dec 30, 2016$318.21M-33.9%
2015Dec 31, 2015$481.16M+9.7%
2014Dec 31, 2014$438.64M+5.3%
2013Dec 31, 2013$416.37M+178.6%
2012Dec 31, 2012$149.44M+0.8%
2011Dec 30, 2011$148.30M–

More Rockwell Medical figures

See a number that looks wrong?